Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 186 participants.

Also called NCT01508325

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 186 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01508325
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01508325. Randomized; no masking; primary purpose supportive care. Start 2011-12 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2015-05-13.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients
Acronym
CREATIVE
Condition
Hypertension
Intervention (Drug)
Bisoprolol
Intervention (Drug)
Metoprolol
Lead sponsor
Merck KGaA, Darmstadt, Germany (class: industry)
Collaborator
Merck Serono Co., Ltd., China (class: industry)

Record details

Record id
cardio:ct-nct01508325
Content hash
e8171975b0a3e29273a79af5170ace816f68749a3cf36bac987b233fb2550e83